Cambridge Healthtech Institute’s 10th Annual
Cell Therapy CMC and Analytics
August 18-19, 2025
Cambridge Healthtech Institute’s Cell Therapy CMC and Analytics conference focuses on the control, characterization, and quality of cell-based therapies, supported by in-depth case studies and insight from leading industry and academic representatives. Topics include CMC regulatory requirements, product and process characterization, potency assay development, quality of starting materials, and commercial-scale challenges, with examples coming from the fields of T cells, NK cells, IPSCs, TILs, and gamma deltas. New for 2025, we will highlight IPSCs, MScs, and regenerative medicine.
Coverage will include, but is not limited to:
- CMC Strategies and Standards for Cell-Based Therapies
- Quality Control Strategies for Cell Therapies
- Analytics Development: Product and Process Characterization
- CMC for Emerging Cell Therapies
- CMC for Cell Therapies for Autoimmune Disorders
- Cryopreservation, Thawing, and Shipping
The deadline for priority consideration is January 27, 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: